SPDR S&P Biotech ETF (XBI)


The SPDR® S&P® Biotech ETF, before expenses, seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. Our approach is designed to provide portfolios with low portfolio turnover, accurate tracking, and lower costs. The S&P Biotechnology Select Industry represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Biotech Index is an equal weighted market cap index. Source: SPDR

Last Trade: $80.61
Trade Time: 07/26/2017
Prev Close: $80.61
Open: $80.76
High: $81.36
Low: $80.55
Volume: 3,013,103
Optionable: No
Yield: 0.222
Annual Dividend: 0.179
Dividend Freq: Quarterly
Leverage: No
Inverse: No
Expense Ratio: 0.350
Inception Date: 01/31/2006
  • Healthcare (99.9327%)

  • United States (99.9020%)
  • (0.0373%)